Mammalian cell culture experiments were completed and Mycobacterium bovis BCG stocks prepared as reported previously (35 (link), 39 (link)). Whole-cell lysates of M. tuberculosis (MtbWL) (NR-14822) were obtained from BEI Resources. Soluble 4-hydroxy-but-2-enyl pyrophosphate (HMBPP; Echelon Bioscience, Salt Lake City, UT) was used for stimulation of γ9δ2 T cells as a control in inhibition assays. Interleukin 2 (IL-2; Hoffmann-LaRoche Inc., Basel, Switzerland) was used to expand γ9δ2 T cells. Anti-CD3 peridinin chlorophyll protein (PerCP; clone SK7), anti-αβ TCR fluorescein isothiocyanate (FITC; clone B3), anti-γδ TCR phycoerythrin (PE; clone 11F2), anti-CD4 PE-cy7 (clone RPA-T4), anti-CD8 V500 (clone RPA-T8), anti-Ki-67 (clone 35/Ki-67), anti-tumor necrosis factor alpha (anti-TNF-α; MAb11), anti-IFN-γ (B27), and anti-granzyme A (anti-GzmA; CB9) were all from BD Biosciences. Guava ViaCount Flex reagent (Millipore; 4700-0060) was used for accurate counting and discrimination of viable and nonviable cells from antigen-expanded cells. All chemicals for biochemical separations were obtained from Acros Organics (silica gel 60) and Sigma-Aldrich (chloroform and methanol). Alkaline phosphatase (AP) was obtained from Fisher Scientific (BP 80975).
Free full text: Click here